Serveur d'exploration sur l'automédication dans le monde francophone

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Cornelia de Lange and Ehlers-Danlos: comorbidity of two rare syndromes.

Identifieur interne : 000F44 ( Main/Exploration ); précédent : 000F43; suivant : 000F45

Cornelia de Lange and Ehlers-Danlos: comorbidity of two rare syndromes.

Auteurs : Cora Cravero [France] ; Vincent Guinchat [France] ; Stéphane Barete [France] ; Angèle Consoli [France]

Source :

RBID : pubmed:26833951

Descripteurs français

English descriptors

Abstract

We present a case of a young adult with both Cornelia de Lange syndrome and Ehlers-Danlos syndrome. The patient showed non-verbal autism, intellectual disability and severe/intractable self-harming behaviours that led to a life-threatening complication (ie, septicaemia). A significant reduction in the self-harming behaviours was attained in a multidisciplinary neurobehavioural inpatient unit after addressing all causes of somatic pains, managing pain using level II and III analgesics, stabilising the patient's mood, limiting the iatrogenic effects of multiple prescriptions and offering a specific psychoeducational approach.

DOI: 10.1136/bcr-2015-210925
PubMed: 26833951
PubMed Central: PMC4746515


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Cornelia de Lange and Ehlers-Danlos: comorbidity of two rare syndromes.</title>
<author>
<name sortKey="Cravero, Cora" sort="Cravero, Cora" uniqKey="Cravero C" first="Cora" last="Cravero">Cora Cravero</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Child and Adolescent Psychiatry, Reference Centre for Rare Psychiatric Diseases, AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Université Pierre et Marie Curie, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Child and Adolescent Psychiatry, Reference Centre for Rare Psychiatric Diseases, AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Université Pierre et Marie Curie, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
<orgName type="university">Université Pierre-et-Marie-Curie</orgName>
</affiliation>
</author>
<author>
<name sortKey="Guinchat, Vincent" sort="Guinchat, Vincent" uniqKey="Guinchat V" first="Vincent" last="Guinchat">Vincent Guinchat</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Child and Adolescent Psychiatry, Reference Centre for Rare Psychiatric Diseases, AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Université Pierre et Marie Curie, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Child and Adolescent Psychiatry, Reference Centre for Rare Psychiatric Diseases, AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Université Pierre et Marie Curie, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
<orgName type="university">Université Pierre-et-Marie-Curie</orgName>
</affiliation>
</author>
<author>
<name sortKey="Barete, Stephane" sort="Barete, Stephane" uniqKey="Barete S" first="Stéphane" last="Barete">Stéphane Barete</name>
<affiliation wicri:level="4">
<nlm:affiliation>Unit of Dermatology, AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Université Pierre et Marie Curie, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Unit of Dermatology, AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Université Pierre et Marie Curie, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
<orgName type="university">Université Pierre-et-Marie-Curie</orgName>
</affiliation>
</author>
<author>
<name sortKey="Consoli, Angele" sort="Consoli, Angele" uniqKey="Consoli A" first="Angèle" last="Consoli">Angèle Consoli</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Child and Adolescent Psychiatry, Reference Centre for Rare Psychiatric Diseases, AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Université Pierre et Marie Curie, Paris, France INSERM U669, Maison de Solenn, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Child and Adolescent Psychiatry, Reference Centre for Rare Psychiatric Diseases, AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Université Pierre et Marie Curie, Paris, France INSERM U669, Maison de Solenn, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
<orgName type="university">Université Pierre-et-Marie-Curie</orgName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2016">2016</date>
<idno type="RBID">pubmed:26833951</idno>
<idno type="pmid">26833951</idno>
<idno type="doi">10.1136/bcr-2015-210925</idno>
<idno type="pmc">PMC4746515</idno>
<idno type="wicri:Area/Main/Corpus">000F02</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000F02</idno>
<idno type="wicri:Area/Main/Curation">000F02</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000F02</idno>
<idno type="wicri:Area/Main/Exploration">000F02</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Cornelia de Lange and Ehlers-Danlos: comorbidity of two rare syndromes.</title>
<author>
<name sortKey="Cravero, Cora" sort="Cravero, Cora" uniqKey="Cravero C" first="Cora" last="Cravero">Cora Cravero</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Child and Adolescent Psychiatry, Reference Centre for Rare Psychiatric Diseases, AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Université Pierre et Marie Curie, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Child and Adolescent Psychiatry, Reference Centre for Rare Psychiatric Diseases, AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Université Pierre et Marie Curie, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
<orgName type="university">Université Pierre-et-Marie-Curie</orgName>
</affiliation>
</author>
<author>
<name sortKey="Guinchat, Vincent" sort="Guinchat, Vincent" uniqKey="Guinchat V" first="Vincent" last="Guinchat">Vincent Guinchat</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Child and Adolescent Psychiatry, Reference Centre for Rare Psychiatric Diseases, AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Université Pierre et Marie Curie, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Child and Adolescent Psychiatry, Reference Centre for Rare Psychiatric Diseases, AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Université Pierre et Marie Curie, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
<orgName type="university">Université Pierre-et-Marie-Curie</orgName>
</affiliation>
</author>
<author>
<name sortKey="Barete, Stephane" sort="Barete, Stephane" uniqKey="Barete S" first="Stéphane" last="Barete">Stéphane Barete</name>
<affiliation wicri:level="4">
<nlm:affiliation>Unit of Dermatology, AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Université Pierre et Marie Curie, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Unit of Dermatology, AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Université Pierre et Marie Curie, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
<orgName type="university">Université Pierre-et-Marie-Curie</orgName>
</affiliation>
</author>
<author>
<name sortKey="Consoli, Angele" sort="Consoli, Angele" uniqKey="Consoli A" first="Angèle" last="Consoli">Angèle Consoli</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Child and Adolescent Psychiatry, Reference Centre for Rare Psychiatric Diseases, AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Université Pierre et Marie Curie, Paris, France INSERM U669, Maison de Solenn, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Child and Adolescent Psychiatry, Reference Centre for Rare Psychiatric Diseases, AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Université Pierre et Marie Curie, Paris, France INSERM U669, Maison de Solenn, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
<orgName type="university">Université Pierre-et-Marie-Curie</orgName>
</affiliation>
</author>
</analytic>
<series>
<title level="j">BMJ case reports</title>
<idno type="eISSN">1757-790X</idno>
<imprint>
<date when="2016" type="published">2016</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adult (MeSH)</term>
<term>Anemia, Iron-Deficiency (drug therapy)</term>
<term>Antidepressive Agents, Second-Generation (therapeutic use)</term>
<term>Cognitive Behavioral Therapy (methods)</term>
<term>Comorbidity (MeSH)</term>
<term>De Lange Syndrome (complications)</term>
<term>De Lange Syndrome (psychology)</term>
<term>De Lange Syndrome (therapy)</term>
<term>Depression (etiology)</term>
<term>Depression (psychology)</term>
<term>Depression (therapy)</term>
<term>Ehlers-Danlos Syndrome (complications)</term>
<term>Ehlers-Danlos Syndrome (psychology)</term>
<term>Ehlers-Danlos Syndrome (therapy)</term>
<term>Fluoxetine (therapeutic use)</term>
<term>Follow-Up Studies (MeSH)</term>
<term>Hospitalization (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Male (MeSH)</term>
<term>Massage (methods)</term>
<term>Morphine (therapeutic use)</term>
<term>Pain (etiology)</term>
<term>Pain (prevention & control)</term>
<term>Pain (psychology)</term>
<term>Pain Management (methods)</term>
<term>Problem Behavior (psychology)</term>
<term>Self Mutilation (etiology)</term>
<term>Self Mutilation (prevention & control)</term>
<term>Self Mutilation (psychology)</term>
<term>Treatment Outcome (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Adulte (MeSH)</term>
<term>Antidépresseurs de seconde génération (usage thérapeutique)</term>
<term>Anémie par carence en fer (traitement médicamenteux)</term>
<term>Automutilation (prévention et contrôle)</term>
<term>Automutilation (psychologie)</term>
<term>Automutilation (étiologie)</term>
<term>Comorbidité (MeSH)</term>
<term>Comportement déviant (psychologie)</term>
<term>Douleur (prévention et contrôle)</term>
<term>Douleur (psychologie)</term>
<term>Douleur (étiologie)</term>
<term>Dépression (psychologie)</term>
<term>Dépression (thérapie)</term>
<term>Dépression (étiologie)</term>
<term>Fluoxétine (usage thérapeutique)</term>
<term>Gestion de la douleur (méthodes)</term>
<term>Hospitalisation (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Massage (méthodes)</term>
<term>Morphine (usage thérapeutique)</term>
<term>Mâle (MeSH)</term>
<term>Résultat thérapeutique (MeSH)</term>
<term>Syndrome d'Ehlers-Danlos (complications)</term>
<term>Syndrome d'Ehlers-Danlos (psychologie)</term>
<term>Syndrome d'Ehlers-Danlos (thérapie)</term>
<term>Syndrome de Cornelia de Lange (complications)</term>
<term>Syndrome de Cornelia de Lange (psychologie)</term>
<term>Syndrome de Cornelia de Lange (thérapie)</term>
<term>Thérapie cognitive (méthodes)</term>
<term>Études de suivi (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Antidepressive Agents, Second-Generation</term>
<term>Fluoxetine</term>
<term>Morphine</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en">
<term>De Lange Syndrome</term>
<term>Ehlers-Danlos Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>Anemia, Iron-Deficiency</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en">
<term>Depression</term>
<term>Pain</term>
<term>Self Mutilation</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en">
<term>Cognitive Behavioral Therapy</term>
<term>Massage</term>
<term>Pain Management</term>
</keywords>
<keywords scheme="MESH" qualifier="méthodes" xml:lang="fr">
<term>Gestion de la douleur</term>
<term>Massage</term>
<term>Thérapie cognitive</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en">
<term>Pain</term>
<term>Self Mutilation</term>
</keywords>
<keywords scheme="MESH" qualifier="prévention et contrôle" xml:lang="fr">
<term>Automutilation</term>
<term>Douleur</term>
</keywords>
<keywords scheme="MESH" qualifier="psychologie" xml:lang="fr">
<term>Automutilation</term>
<term>Comportement déviant</term>
<term>Douleur</term>
<term>Dépression</term>
<term>Syndrome d'Ehlers-Danlos</term>
<term>Syndrome de Cornelia de Lange</term>
</keywords>
<keywords scheme="MESH" qualifier="psychology" xml:lang="en">
<term>De Lange Syndrome</term>
<term>Depression</term>
<term>Ehlers-Danlos Syndrome</term>
<term>Pain</term>
<term>Problem Behavior</term>
<term>Self Mutilation</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en">
<term>De Lange Syndrome</term>
<term>Depression</term>
<term>Ehlers-Danlos Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="thérapie" xml:lang="fr">
<term>Dépression</term>
<term>Syndrome d'Ehlers-Danlos</term>
<term>Syndrome de Cornelia de Lange</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr">
<term>Anémie par carence en fer</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr">
<term>Antidépresseurs de seconde génération</term>
<term>Fluoxétine</term>
<term>Morphine</term>
<term>Syndrome d'Ehlers-Danlos</term>
<term>Syndrome de Cornelia de Lange</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr">
<term>Automutilation</term>
<term>Douleur</term>
<term>Dépression</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adult</term>
<term>Comorbidity</term>
<term>Follow-Up Studies</term>
<term>Hospitalization</term>
<term>Humans</term>
<term>Male</term>
<term>Treatment Outcome</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Adulte</term>
<term>Comorbidité</term>
<term>Hospitalisation</term>
<term>Humains</term>
<term>Mâle</term>
<term>Résultat thérapeutique</term>
<term>Études de suivi</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">We present a case of a young adult with both Cornelia de Lange syndrome and Ehlers-Danlos syndrome. The patient showed non-verbal autism, intellectual disability and severe/intractable self-harming behaviours that led to a life-threatening complication (ie, septicaemia). A significant reduction in the self-harming behaviours was attained in a multidisciplinary neurobehavioural inpatient unit after addressing all causes of somatic pains, managing pain using level II and III analgesics, stabilising the patient's mood, limiting the iatrogenic effects of multiple prescriptions and offering a specific psychoeducational approach. </div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">26833951</PMID>
<DateCompleted>
<Year>2016</Year>
<Month>10</Month>
<Day>25</Day>
</DateCompleted>
<DateRevised>
<Year>2018</Year>
<Month>12</Month>
<Day>02</Day>
</DateRevised>
<Article PubModel="Electronic">
<Journal>
<ISSN IssnType="Electronic">1757-790X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>2016</Volume>
<PubDate>
<Year>2016</Year>
<Month>Feb</Month>
<Day>01</Day>
</PubDate>
</JournalIssue>
<Title>BMJ case reports</Title>
<ISOAbbreviation>BMJ Case Rep</ISOAbbreviation>
</Journal>
<ArticleTitle>Cornelia de Lange and Ehlers-Danlos: comorbidity of two rare syndromes.</ArticleTitle>
<ELocationID EIdType="doi" ValidYN="Y">10.1136/bcr-2015-210925</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">bcr2015210925</ELocationID>
<Abstract>
<AbstractText>We present a case of a young adult with both Cornelia de Lange syndrome and Ehlers-Danlos syndrome. The patient showed non-verbal autism, intellectual disability and severe/intractable self-harming behaviours that led to a life-threatening complication (ie, septicaemia). A significant reduction in the self-harming behaviours was attained in a multidisciplinary neurobehavioural inpatient unit after addressing all causes of somatic pains, managing pain using level II and III analgesics, stabilising the patient's mood, limiting the iatrogenic effects of multiple prescriptions and offering a specific psychoeducational approach. </AbstractText>
<CopyrightInformation>2016 BMJ Publishing Group Ltd.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Cravero</LastName>
<ForeName>Cora</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Department of Child and Adolescent Psychiatry, Reference Centre for Rare Psychiatric Diseases, AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Université Pierre et Marie Curie, Paris, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Guinchat</LastName>
<ForeName>Vincent</ForeName>
<Initials>V</Initials>
<AffiliationInfo>
<Affiliation>Department of Child and Adolescent Psychiatry, Reference Centre for Rare Psychiatric Diseases, AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Université Pierre et Marie Curie, Paris, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Barete</LastName>
<ForeName>Stéphane</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Unit of Dermatology, AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Université Pierre et Marie Curie, Paris, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Consoli</LastName>
<ForeName>Angèle</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Child and Adolescent Psychiatry, Reference Centre for Rare Psychiatric Diseases, AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Université Pierre et Marie Curie, Paris, France INSERM U669, Maison de Solenn, Paris, France.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2016</Year>
<Month>02</Month>
<Day>01</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>BMJ Case Rep</MedlineTA>
<NlmUniqueID>101526291</NlmUniqueID>
<ISSNLinking>1757-790X</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D018687">Antidepressive Agents, Second-Generation</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>01K63SUP8D</RegistryNumber>
<NameOfSubstance UI="D005473">Fluoxetine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>76I7G6D29C</RegistryNumber>
<NameOfSubstance UI="D009020">Morphine</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018798" MajorTopicYN="N">Anemia, Iron-Deficiency</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018687" MajorTopicYN="N">Antidepressive Agents, Second-Generation</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015928" MajorTopicYN="N">Cognitive Behavioral Therapy</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D003635" MajorTopicYN="N">De Lange Syndrome</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
<QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D003863" MajorTopicYN="N">Depression</DescriptorName>
<QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName>
<QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004535" MajorTopicYN="N">Ehlers-Danlos Syndrome</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
<QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005473" MajorTopicYN="N">Fluoxetine</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008405" MajorTopicYN="N">Massage</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009020" MajorTopicYN="N">Morphine</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D010146" MajorTopicYN="N">Pain</DescriptorName>
<QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
<QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D059408" MajorTopicYN="N">Pain Management</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000066553" MajorTopicYN="N">Problem Behavior</DescriptorName>
<QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012652" MajorTopicYN="N">Self Mutilation</DescriptorName>
<QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
<QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="entrez">
<Year>2016</Year>
<Month>2</Month>
<Day>3</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2016</Year>
<Month>2</Month>
<Day>3</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2016</Year>
<Month>10</Month>
<Day>26</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">26833951</ArticleId>
<ArticleId IdType="pii">bcr-2015-210925</ArticleId>
<ArticleId IdType="doi">10.1136/bcr-2015-210925</ArticleId>
<ArticleId IdType="pmc">PMC4746515</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Genet Med. 2011 Apr;13(4):278-94</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21358411</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Med Genet C Semin Med Genet. 2007 Aug 15;145C(3):248-60</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17640042</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Res Dev Disabil. 2015 Mar;38:242-55</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25575287</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Isr J Psychiatry Relat Sci. 2006;43(4):265-74</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17338446</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Autism. 2001 Sep;5(3):265-75</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11708586</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Hum Genet. 2004 Oct;75(4):610-23</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15318302</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int Urol Nephrol. 2012 Aug;44(4):1045-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22160729</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Appl Behav Anal. 2002 Spring;35(1):69-72</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11936548</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Hum Mutat. 2005 Jan;25(1):28-37</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15580559</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Autism. 2007 Jan;11(1):9-17</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17175570</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Dev Behav Pediatr. 2011 May;32(4):332-40</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21502871</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Can Acad Child Adolesc Psychiatry. 2010 May;19(2):100-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20467546</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Med Genet. 1998 Apr 28;77(1):31-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9557891</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Dialogues Clin Neurosci. 2012 Sep;14(3):263-79</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23226952</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pediatrics. 2012 Nov;130 Suppl 2:S98-105</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23118260</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Autism. 2008 Jul;12(4):373-90</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18579645</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Ment Defic Res. 1966 Dec;10(4):241-54</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">5972765</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pain Med. 2015 Dec;16(12 ):2324-37</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26582720</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Med Genet A. 2012 Aug;158A(8):1841-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22740374</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur Psychiatry. 2011 Jan;26(1):34-44</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20542667</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur J Hum Genet. 2007 Feb;15(2):143-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17106445</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Intellect Dev Disabil. 2013 Jul;118(4):262-83</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23937369</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Child Adolesc Psychiatr Clin N Am. 2014 Jan;23(1):41-55</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24231166</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>France</li>
</country>
<region>
<li>Île-de-France</li>
</region>
<settlement>
<li>Paris</li>
</settlement>
<orgName>
<li>Université Pierre-et-Marie-Curie</li>
</orgName>
</list>
<tree>
<country name="France">
<region name="Île-de-France">
<name sortKey="Cravero, Cora" sort="Cravero, Cora" uniqKey="Cravero C" first="Cora" last="Cravero">Cora Cravero</name>
</region>
<name sortKey="Barete, Stephane" sort="Barete, Stephane" uniqKey="Barete S" first="Stéphane" last="Barete">Stéphane Barete</name>
<name sortKey="Consoli, Angele" sort="Consoli, Angele" uniqKey="Consoli A" first="Angèle" last="Consoli">Angèle Consoli</name>
<name sortKey="Guinchat, Vincent" sort="Guinchat, Vincent" uniqKey="Guinchat V" first="Vincent" last="Guinchat">Vincent Guinchat</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/AutomedicationFrancoV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000F44 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000F44 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    AutomedicationFrancoV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:26833951
   |texte=   Cornelia de Lange and Ehlers-Danlos: comorbidity of two rare syndromes.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:26833951" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a AutomedicationFrancoV1 

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Mon Mar 15 15:24:36 2021. Site generation: Mon Mar 15 15:32:03 2021